Home » Topics » Regulatory

Regulatory
RSS

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

U.K. approval for Edronax

April 21, 1997

Imitrex Nasal Spray introduced in Canada

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Generic minoxidil receives FDA approval

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...